Western Health Department of Cardiology, Victoria, Australia; Baker Heart and Diabetes Institute, Victoria, Australia.
Department of Medicine, University of Melbourne, Victoria, Australia.
Cardiovasc Revasc Med. 2024 Aug;65:58-64. doi: 10.1016/j.carrev.2024.02.022. Epub 2024 Mar 4.
To determine the influence of presenting electrocardiographic (ECG) changes on prognosis in acute coronary syndrome cardiogenic shock (ACS-CS) patients undergoing percutaneous coronary angiography (PCI).
The effect of initial ECG changes such as ST-elevation myocardial infarction (STEMI) versus non-STEMI among patients ACS-CS on prognosis remains unclear.
We analysed data from consecutive patients with ACS-CS enrolled in the Victorian Cardiac Outcomes registry between 2014 and 2020. Inverse probability of treatment weighting analysis (IPTW) was used to assess the effect of ECG changes on 30-day mortality.
Of 1564 patients with ACS-CS who underwent PCI, 161 had non-STEMI and 1403 had STEMI on ECG. The mean age was 66 ± 13 years, and 74 % (1152) were males. Patients with non-STEMI compared to STEMI were older (70 ± 12 vs 65 ± 13 years), had higher rates of diabetes (34 % vs 21 %), prior coronary artery bypass graft surgery (14 % vs 3.3 %), peripheral arterial disease (10.6 % vs 4.1 %, p < 0.01), and lower baseline eGFR (53.8 [37.1, 75.4] vs 65.3 [46.3, 87.8] ml/min/1.73m), all p ≤ 0.01. Non-STEMI patients were more likely to have a culprit left circumflex artery (29 % vs 20 %) and more often underwent multivessel percutaneous coronary intervention (30 % vs 20 %) but had lower rates of out-of-hospital cardiac arrest (21 % vs 39 %), all p ≤ 0.01. Propensity score analysis with IPTW confirmed that non-STEMI ECG was associated with lower odds for 30-day all-cause mortality (OR 0.47 [0.32, 0.69], p < 0.001), and 30-day major adverse cardiovascular and cerebrovascular events (OR 0.48 [0.33, 0.70]).
In patients undergoing PCI, Non-STEMI as compared to STEMI on index ECG was associated with approximately half the relative risk of both 30-day mortality and 30-day MACCE and could be a useful variable to integrate in ACS-CS risk scores.
确定在接受经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征心原性休克(ACS-CS)患者中,心电图(ECG)改变对预后的影响。
ACS-CS 患者初始 ECG 改变(如 ST 段抬高型心肌梗死 [STEMI] 与非 ST 段抬高型心肌梗死 [NSTEMI])对预后的影响尚不清楚。
我们分析了 2014 年至 2020 年期间连续纳入维多利亚心脏结局登记处的 ACS-CS 患者的数据。采用逆概率治疗加权分析(IPTW)评估 ECG 改变对 30 天死亡率的影响。
在 1564 例接受 PCI 的 ACS-CS 患者中,161 例 ECG 为 NSTEMI,1403 例为 STEMI。平均年龄为 66 ± 13 岁,74%(1152 例)为男性。与 STEMI 相比,NSTEMI 患者年龄更大(70 ± 12 岁 vs 65 ± 13 岁),糖尿病发生率更高(34% vs 21%),先前接受过冠状动脉旁路移植术(14% vs 3.3%),外周动脉疾病(10.6% vs 4.1%,p<0.01),基线 eGFR 更低(53.8 [37.1,75.4] vs 65.3 [46.3,87.8] ml/min/1.73m),均 p<0.01。NSTEMI 患者更可能存在罪犯左回旋支(29% vs 20%),更常接受多支血管 PCI(30% vs 20%),但院外心脏骤停发生率更低(21% vs 39%),均 p<0.01。采用 IPTW 的倾向评分分析证实,与 STEMI 相比,NSTEMI 心电图与 30 天全因死亡率(OR 0.47 [0.32,0.69],p<0.001)和 30 天主要不良心血管和脑血管事件(OR 0.48 [0.33,0.70])的风险降低相关。
在接受 PCI 的患者中,与 STEMI 相比,NSTEMI 指数 ECG 与 30 天死亡率和 30 天 MACCE 的风险降低相关,可能是 ACS-CS 风险评分中有用的整合变量。